<SEC-DOCUMENT>0001178913-24-000879.txt : 20240308
<SEC-HEADER>0001178913-24-000879.hdr.sgml : 20240308
<ACCEPTANCE-DATETIME>20240308161025
ACCESSION NUMBER:		0001178913-24-000879
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20240308
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240308
DATE AS OF CHANGE:		20240308

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Entera Bio Ltd.
		CENTRAL INDEX KEY:			0001638097
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38556
		FILM NUMBER:		24734418

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT HADASSAH, MINRAV BUILDING
		STREET 2:		FIFTH FLOOR
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9112002
		BUSINESS PHONE:		972-2-532-7151

	MAIL ADDRESS:	
		STREET 1:		KIRYAT HADASSAH, MINRAV BUILDING
		STREET 2:		FIFTH FLOOR
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9112002
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>zk2431116.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:entx="http://enterabio.com/20240308" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_e3793fd0246149fc909fd1fcfc95fa89" contextRef="c20240308to20240308" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_2783e5c0c3ef4b5c98066465eeb39ec2" contextRef="c20240308to20240308">0001638097</ix:nonNumeric><ix:nonNumeric name="dei:CityAreaCode" id="Fact_845dc47bf7764f37ae6b3ec21fdb1f1c" contextRef="c20240308to20240308">972</ix:nonNumeric><ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_5b00f5ad8e2a42019f08b2e5b15a63bf" contextRef="c20240308to20240308">2-532-7151</ix:nonNumeric><ix:nonNumeric name="dei:Security12bTitle" id="Fact_33337dadb56448e6803d820203d94d6e" contextRef="c20240308to20240308_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share</ix:nonNumeric><ix:nonNumeric name="dei:TradingSymbol" id="Fact_a700b67d61a142d989acfd1e03ccdf9c" contextRef="c20240308to20240308_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">ENTXW</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_19ac239564e543ae8bdeb253ce77e391" contextRef="c20240308to20240308_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_90e9abc973f6425ea56ebe4d147111d6" contextRef="c20240308to20240308_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="entx-20240308.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20240308to20240308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638097</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-08</xbrli:startDate><xbrli:endDate>2024-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240308to20240308_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">entx:OrdinarySharesParValueOfNIS00000769Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-08</xbrli:startDate><xbrli:endDate>2024-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20240308to20240308_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001638097</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">entx:WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-08</xbrli:startDate><xbrli:endDate>2024-03-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
    </div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">UNITED STATES</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Washington, D.C. 20549</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_854b9d1282cb4016850c835312cb7428" contextRef="c20240308to20240308">8-K</ix:nonNumeric></div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">CURRENT REPORT</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_24f7136a7a434d1c8823a066ae74f5f0" contextRef="c20240308to20240308" format="ixt:date-monthname-day-year-en">March 8, 2024</ix:nonNumeric></div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_dc6cd0bdce1a4d91ac30bf2333ad64ce" contextRef="c20240308to20240308">Entera Bio Ltd.</ix:nonNumeric><br/>
    </div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Exact Name of Registrant as Specified in Its Charter)</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.01%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_5ccef13b5de64531b55131310f990d6d" contextRef="c20240308to20240308" format="ixt-sec:edgarprovcountryen">Israel</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_8531f7f8deb54d378365f039779ae88e" contextRef="c20240308to20240308">001-38556</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_1fc99da374d94b47827b63bc4df1ea69" contextRef="c20240308to20240308">00-0000000</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 32.01%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(State or other jurisdiction<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br/>
              </span>of incorporation)</div>
          </td>

    <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Commission File Number)</div>
          </td>

    <td style="width: 2%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(I.R.S. Employer<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br/>
              </span>Identification)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_53e7134a8dee464d8f80218269c94f83" contextRef="c20240308to20240308">KIRYAT HADASSAH, MINRAV BUILDING</ix:nonNumeric> &#8211; <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_2921a3eff99c4dd5bff84c01cafc4be3" contextRef="c20240308to20240308">FIFTH FLOOR</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_c317e05c204f4a59a1e4dc8b1f3613c8" contextRef="c20240308to20240308">JERUSALEM</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_5dfe71dfd21e4ab8aee3d679ab8f226a" contextRef="c20240308to20240308" format="ixt-sec:countrynameen">Israel</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_70b738c460a04d3c9513ff7984b36624" contextRef="c20240308to20240308">9112002</ix:nonNumeric></span><br/>
      </span>(Address of principal executive offices) (Zip Code)</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="text-decoration: underline;"><br/>
        <span style="-sec-ix-hidden:Fact_845dc47bf7764f37ae6b3ec21fdb1f1c">+972</span><span style="-sec-ix-hidden:Fact_5b00f5ad8e2a42019f08b2e5b15a63bf">-2-532-7151</span> </span></div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Registrant&#8217;s Telephone Number, Including Area Code)</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;&#160;</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>

    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
      under any of the following provisions (see General Instruction A.2. below):</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_aedbad8e66824d61914f676dc82e5ccb" contextRef="c20240308to20240308" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 96.15%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div style="line-height: 1.25;"><br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_76572359dc7d4cb7bad6d925fd113c86" contextRef="c20240308to20240308" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 96.15%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_25c510ae2a4d49a890418808323caadb" contextRef="c20240308to20240308" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 96.15%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_095cdde2305a4992902e14b13d9e8daf" contextRef="c20240308to20240308" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 96.15%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.01%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title of each class</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Trading Symbol(s)</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: #000000 2px solid;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 32.01%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_ed98f41c93304b78938876a12e4df08c" contextRef="c20240308to20240308_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member">Ordinary Shares, par value of NIS 0.0000769</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_8f25ca98f88f4f82bc488b6b84f08e53" contextRef="c20240308to20240308_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member">ENTX</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 2%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 32%; vertical-align: top; background-color: #CCEEFF;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><span style="-sec-ix-hidden:Fact_90e9abc973f6425ea56ebe4d147111d6">Nasdaq Capital Market</span><br/>
            </div>
          </td>

  </tr>


</table>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
      (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_93ab7cbcbd0b4c55bd07e713e802587e" contextRef="c20240308to20240308" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br/>
    </div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
      complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

    </div>

    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>

    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Item 2.02 Results of Operations and Financial Condition.</div>

        <div style="line-height: 1.25">&#160;</div>

        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">On March <span style="font-family: 'Times New Roman', serif; font-size: 10pt;">8</span>, 2024, Entera Bio Ltd., a company
          organized under the laws of the State of Israel (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; or the &#8220;Company&#8221;), issued a press release announcing <span style="font-family: 'Times New Roman', serif; font-size: 10pt;">its financial results for the fiscal year ended
            December 31, 2023.</span> A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item <span style="font-family: 'Times New Roman', serif; font-size: 10pt;">2.02.</span></div>

        <div style="line-height: 1.25">&#160;</div>

        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Item 7.01 Regulation FD Disclosure.</div>

        <div style="line-height: 1.25">&#160;</div>

        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;"><span style="font-family: 'Times New Roman', serif; font-size: 10pt;">The information contained in Item 2.02 of this
            Current Report on Form 8-K is incorporated by reference in this Item </span>7.01.</div>

        <div style="line-height: 1.25">&#160;</div>

        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">The information contained in this Current Report on Form 8-K, including in Exhibit 99.1 attached hereto, is &#8220;furnished&#8221; and
          not &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing
          under the Exchange Act or the Securities Act of 1933, as amended, except to the extent such other filing specifically incorporates such information by reference.</div>

        <div style="line-height: 1.25">&#160;</div>

        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;">Item 9.01 Financial Statements and Exhibits.</div>

        <div style="line-height: 1.25">&#160;</div>

        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">(d) Exhibits.</div>

        <div style="line-height: 1.25;"><br/>
        </div>

        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;">
            <div>
              <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8.66%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit</div>
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Number</div>
                    </td>

    <td style="width: 1%; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description</div>
                    </td>

  </tr>

  <tr>

    <td style="width: 8.66%; vertical-align: bottom;">
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="exhibit_99-1.htm">99.1</a></div>
                    </td>

    <td style="width: 1%; vertical-align: bottom;"><a href="exhibit_99-1.htm"><br/>
                      </a> </td>

    <td style="width: 90%; vertical-align: bottom;">
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
                        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 10pt;"><a href="exhibit_99-1.htm">Press Release
                            dated March 8, 2024 announcing the Company&#8217;s financial results for the fiscal year ended December 31, 2023.</a></div>
                      </div>
                    </td>

  </tr>

  <tr>

    <td style="width: 8.66%; vertical-align: bottom;">
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
                    </td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom;">
                      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
                        <div style="text-align: justify; line-height: 1.25; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
                      </div>
                    </td>

  </tr>


</table>
            </div>

            <div><br/>
            </div>

          </div>

        </div>

      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

      </div>

      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

          <div style="line-height: 1.25">&#160;</div>

          <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on
            its behalf by the undersigned thereunto duly authorized.</div>

          <div style="line-height: 1.25;"><br/>
          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top;">&#160;</td>

    <td style="width: 3%; vertical-align: bottom;">&#160;</td>

    <td style="vertical-align: bottom;" colspan="2">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ENTERA BIO LTD.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: middle;">&#160;</td>

    <td style="width: 3%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: bottom;">&#160;</td>

    <td style="width: 46%; vertical-align: bottom;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: March&#160; 8, 2024</div>
                </td>

    <td style="width: 3%; vertical-align: bottom;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
                </td>

    <td style="width: 1%; vertical-align: top;">&#160;</td>

    <td style="width: 46%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/s/&#160;Miranda Toledano</div>
                </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: bottom;">&#160;</td>

    <td style="width: 3%; vertical-align: bottom;">&#160;</td>

    <td style="width: 1%; vertical-align: middle;">&#160;</td>

    <td style="width: 46%; vertical-align: bottom;">
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name: Miranda Toledano</div>
                  <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title: Chief Executive Officer</div>
                </td>

  </tr>


</table>
          <div style="line-height: 1.25;"><br/>
          </div>

        </div>

      </div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', serif; font-size: 1pt;">&#160;</div>

      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;&#160;&#160; <br/>
      </div>

    </div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: company
         Document created using Broadridge PROfile 23.9.1.5178
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25; text-align: right;"><font style="font-weight: bold;"><u>Exhibit 99.1</u></font><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><img width="136" height="100" src="image0.jpg"></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">JERUSALEM &#8211; March 8, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (&#8220;Entera&#8221; or the &#8220;Company&#8221;) a leader in the development of
      orally delivered peptides, today reported financial results and key business updates for the fourth quarter and year ended&#160;December 31, 2023.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;2023 was an inflection point for Entera, with consistent validation of our disruptive N-Tab&#8482; oral peptide technology platform and the
      unveiling of our goal to advance five potential first-in-class oral peptide programs, Phase 1 through Phase 3, into the clinic by the end of 2025. Each of these programs has been carefully selected to align with our platform and our mission to
      develop treatments that stand to become<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> the number one choice for patients requiring peptide therapies, in a simple and convenient tablet format. Each of these</font>
      programs is expected to have important catalysts during 2024. Following our December 2023 financing, we expect to have sufficient cash to fund operations through the first half of 2025&#8221;, said&#160;Miranda Toledano, CEO of&#160;Entera.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">EB613: First Oral PTH(1-34) Daily Osteoanabolic Tablets for Osteoporosis</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z04ee0b686b3c442aaaf23c9766204a7f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In March 2023, a Type D meeting between Entera and the U.S. Food and Drug Administration (FDA) re-affirmed that a placebo-controlled phase 3 study design with Bone
              Mineral Density (BMD) and not fracture as primary endpoint could support a New Drug Application for EB613</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" id="z3dd85a6fc0b5433ab305537b80c80b7c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In November 2023, Entera echoed the American Society for Bone and Mineral Research (ASBMR) announcement that the Strategy to Advance BMD as a Regulatory Endpoint
                (SABRE) team had submitted its final qualification plan to the FDA</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc393c947f81042de941fcf85f0e0e268" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At the Annual ASBMR Meeting in October 2023, Entera presented the differentiated pharmacokinetic profile of EB613, versus Forteo&#174; PTH(1-34) 20 <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#956;</font>g which requires a daily subcutaneous injection. EB613 consistently shows an increased Cmax and shorter duration of systemic exposure versus Forteo&#174;.
                Furthermore, EB613&#8217;s brief &#8220;pulsatile&#8221; action appears to simultaneously stimulate both a dual bone formation and a mild anti-resorptive effect, as compared to Forteo&#174;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc0ff29a42fd04282951852c2e6f80c4f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">During the fourth quarter of 2023, Entera submitted its Phase 2 manuscript for potential publication in a major medical journal related to its phase 2, 6-month,
                161-patient, placebo-controlled study in post-menopausal women with low bone mass and osteoporosis which met primary and secondary endpoints</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8220;We expect an update on the qualification process of SABRE and
        BMD as the surrogate endpoint for fracture in 2024. We view this as the final de-risking event from a regulatory standpoint to move EB613 to Phase 3. We believe </font>EB613 stands as the first program to potentially avail itself of the landmark
      SABRE initiative which is also the first biomarker to potentially be approved as part of the 2016 21st&#160;Century Cures Act. As<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> the first potential oral tablet osteoanabolic
        treatment, EB613 holds the potential to address the treatment chasm in this severe, potentially lethal disease which remains significantly undertreated despite efficacious injectable treatments. Fracture rates continue to rise globally, and we have
        not seen any new drugs approved for osteoporosis since 2019 due to the ethical concerns and the costs of fracture endpoint studies. Our discussions with key clinicians and patient advocacy groups and other key stakeholders in this ecosystem
        indicate that an oral anabolic treatment is absolutely warranted and a potential &#8216;game changer&#8217; for the estimated 200 million women with osteoporosis globally. We continue to hold strategic discussions related to EB613 and look forward to
        initiating our pivotal phase 3 study once the final qualification of the SABRE endpoint is announced by FDA,&#8221; said Miranda Toledano, CEO of Entera.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">EB612: First Oral PTH(1-34) Peptide Replacement Therapy Tablets for Hypoparathyroidism</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">EB612, is being developed as the first oral PTH (1-34) peptide replacement treatment for hypoparathyroidism. Entera is currently
      evaluating its hypoparathyroidism program with an improved formulation of EB612 using the naked PTH(1-34) peptide and new intellectual property, tailored to optimize its PK profile and the potential for reduced daily dosing. Entera is also combining
      its N-Tab&#8482; platform with an alternative PTH receptor agonist in a third party collaboration. Entera expects to submit data from the Phase 1 of its next generation EB612 program using the naked PTH(1-34) peptide in the first half of 2024.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">First GLP-2 Peptide Tablets for Short Bowel Syndrome</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Under a collaboration agreement with OPKO Health (&#8220;OPKO&#8221;), Entera is combining its N-Tab&#8482; technology with a proprietary long-acting
        GLP-2 peptide for the development of the first potential daily oral GLP-2 for the treatment of short bowel syndrome and other GI disorders such as Crohn&#8217;s and Celiac disease for which GLP-2 has relevance. Entera published pre-clinical data in May
        2023 demonstrating that its oral peptide delivery platform enables gastric absorption of teduglutide (Gattex&#174;), the only approved GLP-2 treatment, as a convenient potential tablet alternative to daily injections. Pre-IND in vivo PK data for oral
        GLP-2 using OPKO&#8217;s long-acting analogue is expected in the first half of 2024.</div>
      <div style="line-height: 1.25">&#160;</div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">First GLP-1/Glucagon Agonist (Oxyntomodulin) Peptide Tablets for Obesity</div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Under a collaboration agreement with OPKO, Entera is combining its N-Tab&#8482; technology with a proprietary long-acting Oxyntomodulin
        (OXM) peptide for the development of the first potential daily OXM treatment for obesity and other metabolic diseases. Previously, an injectable pegylated version of this OXM peptide demonstrated significant reductions in weight loss and decreased
        plasma triglyceride levels with cardioprotective benefits in over 420 patients in phase 2/2B studies. Pre-IND in vivo PK data for oral OXM using OPKO&#8217;s long acting, modified analogue is expected in mid-2024.</div>
      <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">EB613: First Oral PTH(1-34) Osteoanabolic Tablets to Treat Intense Sport and Military Stress Injuries</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Entera is collaborating with leading researchers in orthopedics and sports medicine to contribute its proprietary oral PTH(1-34) tablets
      for an investigator sponsored Phase 2 Study seeking to treat young women and men athletes that experience stress fractures as a result of intense sports training. More details on this study are expected in the second half of 2024.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Financial Results for the year Ended December 31, 2023</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As of December 31,2023, Entera had cash and cash equivalents of $11.0 million. The Company believes that its existing cash resources
      will be sufficient to meet its projected operating requirements through the second quarter of 2025, which includes the capital required to fund our ongoing operations, including R&amp;D, the completion of the Phase 1 PK study related to our new
      generation platform and the GLP-2/OXM collaborative research we are conducting with OPKO.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Research and development expenses for the year ended December 31, 2023 were $4.5 million, as compared to $5.8 million for the year ended
      December 31, 2022. The decrease of $1.3 million was primarily due to a decrease of $1.5 million in pre-clinical activity and materials costs and a decrease of $0.6 million in employee compensation, including a one-time payment made to a former
      employee pursuant to the terms of his separation agreement. The decrease was partially offset by an increase of $0.8 million in clinical expenses for our Phase 1 PK study related to our new generation platform and new formulations for EB612.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">General and administrative expenses for the year ended December 31, 2023 were $4.4 million, compared to $7.3 million for the year ended
      December 31, 2022. The decrease of $2.8 million was mainly attributable to a decrease of $1.1 million in employee compensation, including a one-time payment to our former employee pursuant to the terms of his separation agreement, a decrease of $0.8
      million as part of a restructuring of professional fees and other advisor expenses, a decrease in Board fees of $0.2 million due to the Board&#8217;s forfeiture of their fees for the third and fourth quarters of 2023 and a decrease of $0.7 million in
      D&amp;O insurance costs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Operating expenses for year ended December 31, 2023 were $8.9 million, as compared to $13.0 million for the year ended December 31,
      2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Net loss was $8.9 million, or $0.31 per ordinary share (basic and diluted), for the year ended December 31, 2023, as compared to $13.1
      million, or $0.45 per ordinary share (basic and diluted), for the year ended December 31, 2022.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">About Entera Bio</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Entera is a clinical stage company focused on developing oral peptide or protein replacement therapies for significant unmet medical
        needs where an oral tablet form holds the potential to transform the standard of care. The Company leverages on a disruptive and proprietary technology platform and its pipeline includes five differentiated, first-in-class oral peptide programs,
        expected to enter the into the clinic (Phase 1 to Phase 3) by 2025. The Company&#8217;s most advanced product candidate, EB613 (oral PTH (1-34), teriparatide), is being developed as the first oral, osteoanabolic (bone building) once-daily&#160;tablet
        treatment for post-menopausal women with low BMD and high-risk osteoporosis, with no prior fracture. A placebo controlled, dose ranging Phase 2 study of EB613 tablets (n= 161) met primary (PD/bone turnover biomarker) and secondary endpoints (BMD).
        Entera is preparing to initiate a Phase 3 registrational study for EB613 pursuant to the FDA&#8217;s qualification of a quantitative BMD endpoint which is expected to occur in 2024. The EB612 program is being developed as the first oral PTH(1-34) tablet
        peptide replacement therapy for hypoparathyroidism. Entera is also developing the first oral oxyntomodulin, a dual targeted GLP1/glucagon peptide, in tablet form for the treatment of obesity; and first oral GLP-2 peptide tablet as an injection-free
        alternative for patients suffering from rare malabsorption conditions such as short bowel syndrome in collaboration with OPKO Health. For more information on Entera Bio, visit www.enterabio.com or follow us on <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>LinkedIn</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Twitter</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Facebook</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Instagram</u></font>.</div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Contact:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Entera Bio:</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ms. Miranda Toledano</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chief Executive Officer</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Entera Bio</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Email: <u>miranda@enterabio.com</u></font></div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u> <br>
        </u></font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Cautionary Statement Regarding Forward Looking Statements</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Various statements in this press release are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform
      Act of 1995. All statements (other than statements of historical facts) in this press release regarding our prospects, plans, financial position, business strategy and expected financial and operational results may constitute forward-looking
      statements. Words such as, but not limited to, &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;design,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;likely,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and &#8220;would,&#8221; or
      the negative of these terms and similar expressions or words, identify forward-looking statements. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties.
      Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Important factors that could cause actual results to differ materially from those reflected in Entera&#8217;s forward-looking statements
      include, among others: changes in the interpretation of clinical data; results of our clinical trials; the FDA&#8217;s interpretation and review of our results from and analysis of our clinical trials; unexpected changes in our ongoing and planned
      preclinical development and clinical trials, the timing of and our ability to make regulatory filings and obtain and maintain regulatory approvals for our product candidates; the potential disruption and delay of manufacturing supply chains; loss of
      available workforce resources, either by Entera or its collaboration and laboratory partners; impacts to research and development or clinical activities that Entera may be contractually obligated to provide; overall regulatory timelines; the size and
      growth of the potential markets for our product candidates; the scope, progress and costs of developing Entera&#8217;s product candidates; Entera&#8217;s reliance on third parties to conduct its clinical trials; Entera&#8217;s expectations regarding licensing,
      business transactions and strategic collaborations; Entera&#8217;s operation as a development stage company with limited operating history; Entera&#8217;s ability to continue as a going concern absent access to sources of liquidity; Entera&#8217;s ability to obtain
      and maintain regulatory approval for any of its product candidates; Entera&#8217;s ability to comply with Nasdaq&#8217;s minimum listing standards and other matters related to compliance with the requirements of being a public company in the United States;
      Entera&#8217;s intellectual property position and its ability to protect its intellectual property; and other factors that are described in the &#8220;Cautionary Statements Regarding Forward-Looking Statements,&#8221; &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and
      Analysis of Financial Condition and Results of Operations&#8221; sections of Entera&#8217;s most recent Annual Report on Form 10-K filed with the SEC, as well as the company&#8217;s subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.&#160;
      There can be no assurance that the actual results or developments anticipated by Entera will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Entera. Therefore, no assurance can be given
      that the outcomes stated or implied in such forward-looking statements and estimates will be achieved. Entera cautions investors not to rely on the forward-looking statements Entera makes in this press release. The information in this press release
      is provided only as of the date of this press release, and Entera undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required
      by law.</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z58e7de0570b74a1b989f6ac35ea2c5bb" class="cfttable">

          <tr>
            <td valign="bottom" style="vertical-align: middle;" colspan="8">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ENTERA BIO LTD.</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle;" colspan="8">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CONSOLIDATED BALANCE SHEETS</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle;" colspan="8">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(U.S. dollars in thousands)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle;" colspan="8">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle;" colspan="2">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">December 31</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">December 31</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"> 2023</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2022</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Unaudited)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle; border-bottom: #000000 solid 2px;" colspan="2">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Audited)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="vertical-align: middle;" colspan="6">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cash and cash equivalents</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">11,019</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">12,309</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accounts receivable and other current assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">238</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">540</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Property and equipment, net</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">100</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">139</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 2px;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Other assets, net</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">408</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">139</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total assets</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">11,765</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">13,127</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accounts payable and other current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,091</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,341</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total non-current liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">288</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">32</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total liabilities</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,379</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1,373</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Total shareholders' equity</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">10,386</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">11,754</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 76%; padding-bottom: 4px;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Total liabilities and shareholders' equity</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">11,765</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
            <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">13,127</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ENTERA BIO LTD.</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">CONSOLIDATED STATEMENTS OF OPERATIONS</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><br>
      </font>(U.S. dollars in thousands, except share and per share data)</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(Unaudited)</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z1121dde21ef74bc185875ae9481fbee1" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: top; border-bottom: #000000 solid 2px;" colspan="6">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-indent: 1pt;">Year Ended</div>
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-indent: 1pt;">December 31,</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-indent: 1pt;"> 2023</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" colspan="2">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-indent: 1pt;">2022</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom;" colspan="2">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">REVENUES</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">134</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">COST OF REVENUES</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">101</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">GROSS PROFIT</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">-</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">33</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">OPERATING EXPENSES:</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Research and development</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,510</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5,848</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">General and administrative</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4,430</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">7,253</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Other income</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(49</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
            </div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(51</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">TOTAL OPERATING EXPENSES</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,891</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">13,050</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">OPERATING LOSS</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,891</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">13,017</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">FINANCIAL INCOME, NET</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(31</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
            </div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(83</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">)</div>
            </div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">LOSS BEFORE INCOME TAX</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,860</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">12,934</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">INCOME TAX EXPENSES</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">29</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">137</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">NET LOSS</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8,889</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">13,071</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">BASIC AND DILUTED LOSS PER SHARE</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.31</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">0.45</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; padding-bottom: 4px;">
            <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF BASIC AND DILUTED LOSS PER SHARE</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">

            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">29,007,794</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">

            <div style="line-height: 1.25;">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">28,808,090</div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">&#160;<br style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageFooter">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>entx-20240308.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.9.1.5178 Broadridge-->
<xs:schema targetNamespace="http://enterabio.com/20240308" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:entx="http://enterabio.com/20240308" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="entx-20240308_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="entx-20240308_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="entx-20240308_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://enterabio.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:element name="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" id="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="OrdinarySharesParValueOfNIS00000769Member" id="entx_OrdinarySharesParValueOfNIS00000769Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>entx-20240308_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.9.1.5178 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://enterabio.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="entx-20240308.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://enterabio.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="entx-20240308.xsd#entx_OrdinarySharesParValueOfNIS00000769Member" xlink:label="OrdinarySharesParValueOfNIS00000769Member" xlink:title="OrdinarySharesParValueOfNIS00000769Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesParValueOfNIS00000769Member" xlink:title="definition: ClassOfStockDomain to OrdinarySharesParValueOfNIS00000769Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="entx-20240308.xsd#entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:label="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="definition: ClassOfStockDomain to WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>entx-20240308_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.9.1.5178 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable_lbl" xml:lang="en-US" id="dei_EntityListingsTable_lbl">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:title="label: EntityListingsTable to dei_EntityListingsTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems_lbl" xml:lang="en-US" id="dei_EntityListingsLineItems_lbl">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems_lbl" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
    <link:loc xlink:type="locator" xlink:href="entx-20240308.xsd#entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:label="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" />
    <link:label xlink:type="resource" xlink:label="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1" xml:lang="en-US" id="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:to="entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1" xlink:title="label: WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember to entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="entx-20240308.xsd#entx_OrdinarySharesParValueOfNIS00000769Member" xlink:label="OrdinarySharesParValueOfNIS00000769Member" xlink:title="OrdinarySharesParValueOfNIS00000769Member" />
    <link:label xlink:type="resource" xlink:label="entx_OrdinarySharesParValueOfNIS00000769Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="entx_OrdinarySharesParValueOfNIS00000769Member_lbl1" xml:lang="en-US" id="entx_OrdinarySharesParValueOfNIS00000769Member_lbl1">Ordinary Shares, par value of NIS 0.0000769 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrdinarySharesParValueOfNIS00000769Member" xlink:to="entx_OrdinarySharesParValueOfNIS00000769Member_lbl1" xlink:title="label: OrdinarySharesParValueOfNIS00000769Member to entx_OrdinarySharesParValueOfNIS00000769Member_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>entx-20240308_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.9.1.5178 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://enterabio.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="entx-20240308.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://enterabio.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="entx-20240308.xsd#entx_OrdinarySharesParValueOfNIS00000769Member" xlink:label="OrdinarySharesParValueOfNIS00000769Member" xlink:title="OrdinarySharesParValueOfNIS00000769Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="OrdinarySharesParValueOfNIS00000769Member" xlink:title="presentation: ClassOfStockDomain to OrdinarySharesParValueOfNIS00000769Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="entx-20240308.xsd#entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:label="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" xlink:title="presentation: ClassOfStockDomain to WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ": -8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WU'61%=&#
M*PR&!R#3J@LX#;6<4+,&*+C(%3T %%%% !1110 4444 %%%% !1110 4444
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MA( R3Q7&MJ/BC4O^/:U-NA[A-O'U;^E1'PMK5Z0UY>)]))6<C^GZUSO%R?\
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140289405166192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  08,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Entera Bio Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001638097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">KIRYAT HADASSAH, MINRAV BUILDING<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">FIFTH FLOOR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">JERUSALEM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">9112002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">2-532-7151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=entx_OrdinarySharesParValueOfNIS00000769Member', window );">Ordinary Shares, par value of NIS 0.0000769 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, par value of NIS 0.0000769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ENTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember', window );">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ENTXW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=entx_OrdinarySharesParValueOfNIS00000769Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=entx_OrdinarySharesParValueOfNIS00000769Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04
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MYHOA/UY_ 5!+ 0(4 Q0    ( $N!:%@'04UB@0   +$    0
M  "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 2X%H6(G['%GN
M    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L!
M A0#%     @ 2X%H6)E<G",0!@  G"<  !,              ( !S $  'AL
M+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !+@6A8+(KS*B(%  "=%@
M&               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L!
M A0#%     @ 2X%H6)^@&_"Q @  X@P   T              ( !90T  'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " !+@6A8EXJ[',     3 @  "P
M        @ %!$   7W)E;',O+G)E;'-02P$"% ,4    " !+@6A8'#AEZC\!
M   \ @  #P              @ $J$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ 2X%H6"0>FZ*M    ^ $  !H              ( !EA(  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 2X%H6&60>9(9 0
MSP,  !,              ( !>Q,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      D "0 ^ @  Q10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="zk2431116.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://enterabio.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>entx-20240308.xsd</File>
    <File>entx-20240308_def.xml</File>
    <File>entx-20240308_lab.xml</File>
    <File>entx-20240308_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="zk2431116.htm">zk2431116.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zk2431116.htm": {
   "nsprefix": "entx",
   "nsuri": "http://enterabio.com/20240308",
   "dts": {
    "schema": {
     "local": [
      "entx-20240308.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "entx-20240308_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "entx-20240308_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "entx-20240308_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "zk2431116.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 8,
    "http://xbrl.sec.gov/dei/2023": 8
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 35,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 26
   },
   "report": {
    "R1": {
     "role": "http://enterabio.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20240308to20240308",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431116.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20240308to20240308",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zk2431116.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "entx_OrdinarySharesParValueOfNIS00000769Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://enterabio.com/20240308",
     "localname": "OrdinarySharesParValueOfNIS00000769Member",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ordinary Shares, par value of NIS 0.0000769 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "entx_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://enterabio.com/20240308",
     "localname": "WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://enterabio.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001178913-24-000879-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178913-24-000879-xbrl.zip
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M$E$?A/]"0"[YGNS)O$25@9E3-1]GL;&:0'/!)-(W/P/IMG>50S7HC%@UW:&
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MBK[1I\$.X:VN&+C!ZS-LV]VS6[O@UEYT:AG?>QK%./BOOS;^5, FA%!6A*Z
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M>&ULU5Q=<]HX%'W?F?T/7O:9[Z8-F:8=EB:[S*:!">QV=U\ZPI9!4]MB)-/
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M9KMQ0LA*$ 0"TQK[(*M'4S9Q>00S> 1A 'R"W-B_$XZ+2E<//)(P0"09M^\
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MB%]B' 0/W7[F@.FZRR]E;O!+F2_%ZYI.]_Z EY(Y%]MDSQO]L:])XD.KG)7
MG%+ARL=__$N+_5OXYRMLM,]Z%ZQW#?N]O80'UK37Y9\0-!_Y)8.93.>)"/0O
MFT=\;\/$M^2[!,\7;X7_"FV]WJC;MFC4Q?"H.;#J[5;[J,7%<;-='PZ$R*F?
MF:_09F3CG&^XFD\@+%5T&__$PC-6 "KL>5]7.)PUB!X3YT_UD=?Y41I%C8YO
MPYSP%''5?X-&9%VX9"^RO8J[[LQGQBJ+K<;9:T^BE^)\>V+&<"S9^0DK>-'W
M4MX*1S_P";,M9XF2*K>7*I=_#FW+B7+E<GJ%I+=6.L]3\3.&W=1W@4IPK@Z<
MJ[=67MR0L4P2JLVO)R5UT_UW]^I;M_^34JXX=>3;546^%37DKQQ0KVY*LZZK
M>+SDEY)?5IJ 6E!'\H8XYG4U]%,.NBZ"0C[K]6\Q\+XVQ;P^][.()_INQWF^
M+_&QUZ.Y-^<GO])9P"5/E3RU3IZJUY8<>O!VN*ITP1=J_,\WO7Z?7=_T+BYO
M2S>\="M*-[QTPTM^*2R_'"Q(7;XAAGE5)5U$]:LKW*X^L^Y_KKM7_6[__6MK
MX>+(B\)(@D=Y?(WYI16T<I?445)'Z04MU:$W(A0\L,94Q&N+.^%*^BIOZ?Z4
MYMR:S;EFI55?\"'>-V31E3Q3\LQJ>:95:3<7G)WXAGCF+7M!.Y\^"U\$^-4^
MT+[<]AS?":. 1\Z=*#V?XMFV:U:'S8,"J,/2[RII<XXVCRJ-5@&";\53*"L\
MV&WMNDA]YMWQ+>F]NO;9S$%0;_(8J+=T"%3!*@%VFTO.6]VTX'O%\Z,*C9"]
M%:*CE%6EK'I+LJJU355+I:Q:@HZR])J.Y^O==KZP^7QP68)=EHL6C<_;E?:R
MK[D54O269=@E7VT#7]4/*K76@@#HVV*L,AKU,_5A7WK]S=@"I=NW1?+O5W#[
MMLWZ*'!U1<GO);\7GM_1*JHO.?OX5V/X,E:"5M'%Y57GZNRR\X5=7IWUOG8K
M[*K[^MUKI4-7.G3/C5 ?;).A\@O&GDN94,J$=<N$=J&.'RUEPGKS45L;BL(
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M"8\,J/&U!\]C3&GQ_#R'7;<^38?\0?ZO+4Z^9N;+[(2/VW%IW)J?^*%\#+1
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M+#;[A1&A[./".)S+[=PFJZR6>UA:A-]OQ]$9&_+)^@GFY%YJ;I #7,\O+O$
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M1*<M^!RFHZ#U;U!+ 0(4 Q0    ( $R!:%BOK<[*_@,  &<2   1
M      "  0    !E;G1X+3(P,C0P,S X+GAS9%!+ 0(4 Q0    ( $R!:%@=
M##Z1)@<  $Y&   5              "  2T$  !E;G1X+3(P,C0P,S X7V1E
M9BYX;6Q02P$"% ,4    " !,@6A8[>"!LY<*  "Q;0  %0
M@ &&"P  96YT>"TR,#(T,#,P.%]L86(N>&UL4$L! A0#%     @ 3(%H6  7
M^R$N!P  V4X  !4              ( !4!8  &5N='@M,C R-# S,#A?<')E
M+GAM;%!+ 0(4 Q0    ( $R!:%AW"*@K-B0   YQ 0 0              "
M ;$=  !E>&AI8FET7SDY+3$N:'1M4$L! A0#%     @ 3(%H6.)D>6R@%
MJ(H   T              ( !%4(  'IK,C0S,3$Q-BYH=&U02P4&      8
,!@"! 0  X%8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>zk2431116_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:entx="http://enterabio.com/20240308"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="entx-20240308.xsd" xlink:type="simple"/>
    <context id="c20240308to20240308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
        </entity>
        <period>
            <startDate>2024-03-08</startDate>
            <endDate>2024-03-08</endDate>
        </period>
    </context>
    <context id="c20240308to20240308_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">entx:OrdinarySharesParValueOfNIS00000769Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-08</startDate>
            <endDate>2024-03-08</endDate>
        </period>
    </context>
    <context id="c20240308to20240308_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001638097</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">entx:WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-08</startDate>
            <endDate>2024-03-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20240308to20240308"
      id="Fact_e3793fd0246149fc909fd1fcfc95fa89">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20240308to20240308"
      id="Fact_2783e5c0c3ef4b5c98066465eeb39ec2">0001638097</dei:EntityCentralIndexKey>
    <dei:CityAreaCode
      contextRef="c20240308to20240308"
      id="Fact_845dc47bf7764f37ae6b3ec21fdb1f1c">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20240308to20240308"
      id="Fact_5b00f5ad8e2a42019f08b2e5b15a63bf">2-532-7151</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="c20240308to20240308_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember"
      id="Fact_33337dadb56448e6803d820203d94d6e">Warrants, each Warrant exercisable for half of an Ordinary Share at an exercise price of $5.85 per Ordinary Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240308to20240308_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember"
      id="Fact_a700b67d61a142d989acfd1e03ccdf9c">ENTXW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20240308to20240308_StatementClassOfStockAxis_WarrantsEachWarrantExercisableForHalfOfAnOrdinaryShareAtAnExercisePriceOf585PerOrdinaryShareMember"
      id="Fact_19ac239564e543ae8bdeb253ce77e391">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20240308to20240308_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member"
      id="Fact_90e9abc973f6425ea56ebe4d147111d6">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20240308to20240308"
      id="Fact_854b9d1282cb4016850c835312cb7428">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20240308to20240308"
      id="Fact_24f7136a7a434d1c8823a066ae74f5f0">2024-03-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20240308to20240308"
      id="Fact_dc6cd0bdce1a4d91ac30bf2333ad64ce">Entera Bio Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20240308to20240308"
      id="Fact_5ccef13b5de64531b55131310f990d6d">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20240308to20240308"
      id="Fact_8531f7f8deb54d378365f039779ae88e">001-38556</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20240308to20240308"
      id="Fact_1fc99da374d94b47827b63bc4df1ea69">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20240308to20240308"
      id="Fact_53e7134a8dee464d8f80218269c94f83">KIRYAT HADASSAH, MINRAV BUILDING</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20240308to20240308"
      id="Fact_2921a3eff99c4dd5bff84c01cafc4be3">FIFTH FLOOR</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20240308to20240308"
      id="Fact_c317e05c204f4a59a1e4dc8b1f3613c8">JERUSALEM</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20240308to20240308"
      id="Fact_5dfe71dfd21e4ab8aee3d679ab8f226a">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20240308to20240308"
      id="Fact_70b738c460a04d3c9513ff7984b36624">9112002</dei:EntityAddressPostalZipCode>
    <dei:WrittenCommunications
      contextRef="c20240308to20240308"
      id="Fact_aedbad8e66824d61914f676dc82e5ccb">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20240308to20240308"
      id="Fact_76572359dc7d4cb7bad6d925fd113c86">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20240308to20240308"
      id="Fact_25c510ae2a4d49a890418808323caadb">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20240308to20240308"
      id="Fact_095cdde2305a4992902e14b13d9e8daf">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20240308to20240308_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member"
      id="Fact_ed98f41c93304b78938876a12e4df08c">Ordinary Shares, par value of NIS 0.0000769</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240308to20240308_StatementClassOfStockAxis_OrdinarySharesParValueOfNIS00000769Member"
      id="Fact_8f25ca98f88f4f82bc488b6b84f08e53">ENTX</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20240308to20240308"
      id="Fact_93ab7cbcbd0b4c55bd07e713e802587e">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
